Monday, June 8, 2026

Sam Chun Dang Pharm Signs 100 Million USD Licensing Deal for Oral Generics of Rybelsus and Wegovy

Sam Chun Dang Pharm secures a U.S. licensing deal for generic diabetes and obesity medications, valued at $100 million.

BTS Jin’s Celebration Marred by Overzealous Fan Antics

The police have initiated a preliminary investigation...

Nvidia and Eli Lilly: How AI is Revolutionizing Drug Development in 2026

Nvidia partners with Eli Lilly to enhance AI in drug development, aiming to revolutionize the biotech industry.

Tag: nanoparticles

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Revolutionary Vaccine Technology: How One Shot Can Triple Immunity Duration with Mussel Protein

POSTECH has developed a single-dose vaccine technology using mussel proteins for long-lasting immunity, promising mass production potential.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.